Lutris Pharma Shares Promising Phase 2 Results for LUT014 Gel at EADV Congress #Israel #Tel_Aviv #LUT014 #Gefitinib #Anti-Cancer
@newsen.bsky.socialExplore
@newsen.bsky.social
@newsen.bsky.socialLutris Pharma Shares Promising Phase 2 Results for LUT014 Gel at EADV Congress #Israel #Tel_Aviv #LUT014 #Gefitinib #Anti-Cancer